1. The Role of Psychosocial Stress on Cardiovascular Disease in Women: JACC State-of-the-Art Review.
- Author
-
Ebong IA, Quesada O, Fonkoue IT, Mattina D, Sullivan S, Oliveira GMM, Spikes T, Sharma J, Commodore Y, Ogunniyi MO, Aggarwal NR, and Vaccarino V
- Subjects
- Humans, Female, Women's Health, Stress, Psychological psychology, Stress, Psychological epidemiology, Cardiovascular Diseases psychology, Cardiovascular Diseases epidemiology
- Abstract
Psychosocial stress can affect cardiovascular health through multiple pathways. Certain stressors, such as socioeconomic disadvantage, childhood adversity, intimate partner violence, and caregiving stress, are especially common among women. The consequences of stress begin at a young age and persist throughout the life course. This is especially true for women, among whom the burden of negative psychosocial experiences tends to be larger in young age and midlife. Menarche, pregnancy, and menopause can further exacerbate stress in vulnerable women. Not only is psychosocial adversity prevalent in women, but it could have more pronounced consequences for cardiovascular risk among women than among men. These differential effects could reside in sex differences in responses to stress, combined with women's propensity toward vasomotor reactivity, microvascular dysfunction, and inflammation. The bulk of evidence suggests that targeting stress could be an important strategy for cardiovascular risk reduction in women., Competing Interests: Funding Support and Author Disclosures Dr Ebong is supported by grants R21 HL165018-01 and U01 HL160274 from the National Heart, Lung, and Blood Institute (NHLBI) and grant 23SFRNPCS1064232 from the American Heart Association Strategically Focused Research Network. Dr Quesada is supported by National Institutes of Health (NIH) grant K23 HL151867. Dr Fonkoue is supported by NIH grants K01HL161027 and UL1TR002494. Dr Ogunniyi has received institutional research support grants from AstraZeneca, Boehringer Ingelheim, Cardurion Pharmaceuticals, and Pfizer, outside the submitted work. Dr Vaccarino is supported by NHLBI grants R01 HL109413 and R01 HL163998. The other authors have reported that they have no relationships relevant to the contents of this paper to disclose., (Copyright © 2024 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF